15 June 2020 – New COVID-19 vaccine moves into first human trials

Type of Intervention: New Tool / Service / Body, Specific Action
Sectors Involved: Health, Research and Development
Level of Jurisdiction: Supranational
Lead People/Agency: BEIS
Imperial College
Vaccine Taskforce

Overview: Clinical researchers will begin human trials of a new £41m government-funded coronavirus vaccine, developed by research at Imperial College London.
Full details here: https://www.gov.uk/government/news/government-funded-imperial-college-covid-19-vaccine-moves-into-first-human-trials

Other links: 1 2
Type of Justification: Scientific Evidence (e.g. academic paper, report)
Source of Evidence or Justification: National – academic
Evidence/Justification: “The vaccine has undergone rigorous pre-clinical safety tests and has been shown to be safe and produced encouraging signs of an effective immune response in animal studies. Over the coming weeks, 300 healthy participants will receive two doses of the vaccine.” – gov.uk website